In this episode of Exploration Science, Dr. David Shoultz,

Chief Operating Officer & Co-Founder of Monod Bio discusses the next

generation of clinical diagnostics and how the company is transforming point of

care for patients. Tune in and learn how scientists at Monod Bio are driving

diagnostic innovation through de novo protein design and

deploying lucCage technology. This platform is based on research conducted

by Dr. David Baker and scientists at the University of Washington Institute for

Protein Design to generate artificial luciferases with optimized size,

stability, substrate specificity, and photophysical properties.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Dr. Wendy Hartsock and Dr. Diedra Shorty. Innehållet i podden är skapat av Dr. Wendy Hartsock and Dr. Diedra Shorty och inte av, eller tillsammans med, Poddtoppen.